The role of GM1 ganglioside in regulating excitatory opioid effects

Annals of the New York Academy of Sciences

Volumn 845, Issue , 1998, Pages 126-138

  Wu, G ^a   Lu, Z H ^a   Wei, T J ^a   Howells, R D ^a   Christoffers, K ^a   Ledeen, R W ^a  

^a RUTGERS NEW JERSEY MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENYLATE CYCLASE; DELTA OPIATE RECEPTOR; GANGLIOSIDE GM1; OPIATE; STIMULATORY GUANINE NUCLEOTIDE BINDING PROTEIN;

ANIMAL CELL; CELL CULTURE; CONFERENCE PAPER; CONFORMATIONAL TRANSITION; CONTROLLED STUDY; ENZYME ACTIVATION; GENETIC TRANSFECTION; NERVE CELL; NEUROBLASTOMA CELL; NONHUMAN; PROTEIN CONFORMATION; RECEPTOR BINDING;

ANIMALIA;

EID: 0031904517     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.1998.tb09666.x     Document Type: Conference Paper

References (72)

1. NAGAI, Y. & S. TSUJI. 1988. Cell biological significance of gangliosides in neural differentiation and development: Critique and proposals. In New Trends in Ganglioside Research: Neurochemical and Neuroregenerative Aspects, R. W. Ledeen, E. L. Hogan, G. Tettamanti, A. J. Yates, and R. K. Yu, Eds.: 329-350. Liviana Press. Padova.
2. TETTAMANTI, G. & L. RIBONI. 1993. Gangliosides and modulation of the function of neural cells. Adv. Lipid Res. 25: 235-267.
3. YATES, A. J., J. D. WALTERS, C. L. WOOD & J. D. JOHNSON. 1989. Ganglioside modulation of cyclic AMP-dependent protein kinase and cyclic nucleotide phosphodiesterase in vitro. J. Neurochem. 53: 162-167.
4. AKAKANE, A., K. FUKUNAGA, S. ARAKI, S. ABE, M. SATAKE, K. MIYAZAKI, H. OKAMURA & E. MIYAMOTO. 1994. Glycolipids isolated from Aplysia kurodai can activate cyclic adenosine 3′, 5′-monophosphate-dependent protein kinase from rat brain. J. Neurochem. 62: 86-93.
5. DALY, J. W. 1981. The effect of gangliosides on the activity of adenylate cyclase and phosphodiesterase from rat cerebral cortex. In Gangliosides in Neurological and Neuromuscular Function, Development, and Repair, M. M. Rapport & A. Gorio, Eds.: 55-66. Raven Press. New York.
6. BERRY-KRAVIS, E. & G. DAWSON. 1985. Possible role of gangliosides in regulating an adenylate cyclase-linked 5-hydroxytryptamirie (5HT,) receptor. J. Neurochem. 45: 1739-1747.
7. MULLIN, B. R., P. H. FISHMAN, G. LEE, S. M. ALOJ, F. D. LEDLEY, R. J. WINAND, L. D. KOHN & R. O. BRADY. 1976. Thyrotropine-ganglioside interactions and their relationship to the structure and function of thyrotropin receptors. Proc. Natl. Acad. Sci. USA 73: 842-846.
8. DEPAUW, H., M. DE WOLF, G. VAN DESSEL, A. LAGROU, H. J. HILDERSON & W. DIERICK. 1990. Modification of the adenylate cyclase of bovine thyroid plasma membranes by manipulating the ganglioside composition with a nonspecific lipid transfer protein. Biochim. Biophys. Acta 1024: 41-18.
9. 1,-adrenergic receptor-induced cyclic AMP formation in Sf9 cells. Biochim. Biophys. Acta 1267: 1-5.
10. SHEN, K.-F., S. M. CRAIN & R. W. LEDEEN. 1991. Brief treatment of sensory neurons with GM1 ganglioside enhances the efficacy of opioid excitatory effects on the action potential. Brain Res. 559: 130-138.
11. CRAIN, S. M. & K.-F. SHEN. 1992. After GM1 ganglioside treatment of sensory neurons naloxone paradoxically prolongs the action potential but still antagonizes opioid inhibition. J. Pharmacol. Exp. Then 260: 182-186.
12. Wu, G., Z.-H. Lu & R. W. LEDEEN. 1997. Interaction of δ-opioid receptor with GM1 ganglioside: Conversion from inhibitory to excitatory mode. Mol. Brain Res. 44: 341-346.
13. HUANG, L.-Y. M. 1992. The excitatory effect of opioids. Neurochem. Int. 20: 463-468.
14. SMART, D. & D. G. LAMBERT. 1996. The stimulatory effects of opioids and their possible role in the development of tolerance. Trend. Pharmacol. Sci. 17: 264-269.
15. CRAIN, S. M. & K.-F. SHEN. 1990. Opioids can evoke direct receptor-mediated excitatory effects on sensory neurons. Trend. Pharmacol. Sci. 11: 77-81.
16. CRAIN, S. M. & K.-F. SHEN. 1996. Modulatory effects of Gs-coupled excitatory opioid receptor functions on opioid analgesia, tolerance, and dependence. Neurochem. Res. 21: 1347-1351.
17. SARNE, Y., A. FIELDS, O. KEREN & M. GAFNI. 1996. Stimulatory effects of opioids on transmitter release and possible cellular mechanisms: Overview and original results. Neurochem. Res. 21: 1353-1361.
18. SHEN, K.-F. & S. M. CRAIN. 1989. Dual opioid modulation of the action potential duration of mouse dorsal root ganglion neurons in culture. Brain Res. 491: 227-242.
19. SIIEN, K.-F. & S. M. CRAIN. 1990. Cholera toxin-B subunit blocks opioid excitatory effects on sensory neuron action potentials indicating the GM-1 ganglioside may regulate Gslinked opioid receptor functions. Brain Res. 531: 1-7.
20. FISHMAN, P. H. 1982. Role of membrane gangliosides in the binding and action of bacterial toxin. J. Membrane Biol. 69: 85-97.
21. Wu, G. & R. W. LEDEEN. 1988. Quantification of gangliotetraose gangliosides with cholera toxin. Anal. Biochem. 173: 368-375.
22. FISHMAN, P. H., T. PACUSZKA & P. A. ORLANDI. 1993. Gangliosides as receptors for bacterial enterotoxins. Adv. Lipid Res. 25: 165-187.
23. CRAIN, S. M. & K.-F. SHEN. 1992. After chronic opioid exposure sensory neurons become supersensitive to the excitatory effects of opioid agonists and antagonists as occurs after acute elevation of GM1 ganglioside. Brain Res. 575: 13-24.
24. CRAIN, S. M. & K.-F. SHEN. 1995. Chronic morphine-treatment sensory neurons remain supersensitive to the excitatory effects of naloxone for months after return to normal culture medium: An in vitro model of "protracted opioid dependence." Brain Res. 694: 103-110.
25. + currents. J. Neurosci. Res. 42: 493-503.
26. CRAIN, S. M. & K.-F. SHEN. 1998. GM1 Ganglioside-induced modulation of opioid receptormediated functions. This issue.
27. SCHEIDELER, M. A. & G. DAWSON. 1986. Direct demonstration of the activation of UDP-N-acetylgalactosamine: [GM3] N-acetyl-galactosaminyltransferase by cyclic AMP. J. Neurochem. 46: 1639-1643.
28. SELF, D. W. & E. J. NESTLER. 1995. Molecular mechanisms of drug reinforcement and addiction. Annu. Rev. Neurosci. 18: 463-495.
29. FRANCEL, P. C., K. HARRIS, M. SMITH, M. C. FISHMAN, G. DAWSON & R. J. MILLER. 1987. Neurochemical characteristics of a novel dorsal root ganglion × neuroblastoma hybrid cell line, F-11, J. Neurochem. 48: 1624-1631.
30. CRUCIANI, R. A., B. DVORKIN, S. A. MORRIS, S. M. CRAIN & M. H. MAKMAN. 1993. Direct coupling of opioid receptor to both stimulatory and inhibitory guanine nucleotide-binding proteins in F-11 neuroblastoma-sensory neuron hybrid cells. Proc. Natl. Acad. Sci. USA 90: 3019-3023.
31. + in F11 neuroblastoma × DRG neuron hybrid cells via cholera toxin-sensitive receptors. Brain Res. 605: 214-220.
32. + conductance of DRG neurons and neuroblastoma × DRG neuron hybrid F11 cells. Brain Res. 696: 97-105.
33. 3H]forskolin. Meth. Enzymol. 195: 52-65.
34. GJERTSEN, B. T., G. MELLGREN, A. OTTEN, E. MARONDE, H. G. GENIESER, B. JASTORFF, O. K. VINTERMYR, G. S. McKNIGHT & S. O. DOSKELAND. 1995. Novel (Rp)-cAMPs analogs as tools for inhibition of cAMP-kinase in cell culture. J. Biol. Chem. 270: 20599-20607.
35. ABE, A., N. S. RADIN, J. A. SHAYMAN, L. L. WOTRING, R. E. ZIPKIN, R. SIVAKUMAR, J. M. RUGGIERI, K. G. CARSON & B. GANEM. 1995. Structural and stereochemical studies of potent inhibitors of glucosylceramide synthase and tumor cell growth. J. Lipid Res. 36: 611-621.
36. AMMER, H. & R. SCHULZ. 1993. Coupling of prostaglandin E1 receptors to the stimulatory GTP-binding protein Gs is enhanced in neuroblastoma × Glioma (NG108-15) hybrid cells chronically exposed to an opioid. Mol. Pharmacol. 43: 556-563.
37. 1, receptor system in neuroblastoma × glioma (NG108-15) hybrid cells. J. Neurochem. 64: 2449-2457.
38. Wu, G., Z.-H. Lu & R. W. LEDEEN. 1996. GM1 ganglioside modulates prostaglandin E1 stimulated adenylyl cyclase in Neuro-2A cells. Glycoconjugate J. 13: 235-239.
39. TENCONI, B., E. LESMA, A. M. DIGIULIO & A. GORIO. 1996. High opioid doses inhibit whereas low doses enhance neuritogenesis in PC12 cells. Dev. Brain Res. 94: 175-181.
40. DAHMS, N. M. & R. L. SCHNAAR. 1983. Ganglioside composition is regulated during differentiation in the neuroblastoma × glioma hybrid cell line NG108-15. J. Biol. Chem. 3: 806-817.
41. Wu, G., Y. FANG, Z.-H. Lu & R. W. LEDEEN. 1998. Induction of axon-Iike and dendrite-Iike processes in neuroblastoma cells. J. Neurocytol. In Press
42. Wu, G., Z.-H. Lu & R. W. LEDEEN. 1991. Correlation of gangliotetraose gangliosides with neurite forming potential of neuroblastoma cells. Devl. Brain Res. 61: 217-228.
43. Wu, G. & R. W. LEDEEN. 1991. Stimulation of neurite outgrowth in neuroblastoma cells by neuraminidase: Putative role of GM1 ganglioside in differentiation. J. Neurochem. 56: 95-104.
44. WANG, L. & A. R. GINTZLER. 1994. Bimodal opioid regulation of cyclic AMP formation: Implications for positive and negative coupling of opiate receptors to adenylyl cyclase. J. Neurochem. 63: 1726-1730.
45. WANG, L. & A. R. GINTZLER. 1997. Altered μ-opiate receptor-G protein signal transduction following chronic morphine exposure. J. Neurochem. 68: 248-254.
46. ONALI, P. & M. C. OLIANAS. 1991. Naturally occurring opioid receptor agonists stimulate adenylate cyclase activity in rat olfactory bulb. Mol. Pharmacol. 39: 436-441.
47. LAURENT, S., J. D. MARSH & T. W. SMITH. 1986. Enkephalins increase cyclic adenosine monophosphate content, calcium uptake, and contractile state in cultured chick embryo heart cells. J. Clin. Invest. 77: 1436-1440.
48. FIELDS, A. & Y. SARNE. 1997. The stimulatory effect of opioids on cyclic AMP production in SK-N-SH cells is mediated by calcium ions. Life Sci. 61: 595-602.
49. 2+ mobilization in single cells of bradykinin-sensitized differentiated neuroblastoma (NO 108-15) cells. Neurosci. Lett. 148: 93-96.
50. JIN, W, N. M. LEE, H. H. LOH & S. A. THAYER. 1992. Dual excitatory and inhibitory effects of opioids on intracellular calcium in neuroblastoma X glioma hybrid NG108-15 cells. Mol. Pharmacol. 42: 1083-1089.
51. FIELD, A., M. GAFNI, Y. ORON & Y. SARNE. 1995. Multiple effects of opiates on intracellular calcium level and on calcium uptake in three neuronal cell lines. Brain Res. 687: 94-102.
52. a2+], in ND8-47 neuroblastoma × dorsal root ganglion hybrid cells is mediated through G protein-coupled δ-opioid receptors and desensitized by chronic exposure to opioid. J. Neurochem. 65: 1612-1621.
53. 2-adrenergic receptors to two G-proteins with opposing effects. J. Biol. Chem. 267: 15795-15801.
54. Wu, G., Z.-H. Lu, P. ALFINITO & R. W. LEDEEN. 1997. Opioid receptor and calcium channel regulation of adenylyl cyclase, modulated by GM1, in NG108-15 cells: Competitive interactions. Neurochem. Res. 22: 1281-1289.
55. DACREMONT, G., M. DE BAETS, J. M. KAUFMAN, A. ELEWAUT & A. VERMEULEM. 1984. Inhibition of adenylate cyclase activity of human thyroid membranes by gangliosides. Biochim. Biophys. Acta 770: 142-147.
56. LAUGWITZ, K.-L., A. ALLGEIER, S. OFFERMANNS, K. SPICHER, J. VAN SANDE, J. E. DUMONT & G. SCHULTZ. 1996. The human thyrotropin receptor: A heptahelical receptor capable of stimulating membranes of all four G protein families. Proc. Natl. Acad. Sci. USA 93: 116-120.
57. IIDA-KLEIN, A., J. Guo, L. Y. XIE, H. JUPPNER, J. T. POTTS, H. M. KRONENBERG, F. R. BRINGHURST, A. B. ABOU-SAMRA & V. SEGRE. 1995. Truncation of the carboxyl-terminal region of the rat parathyriod hormone (PTH)/PTH-related receptor enhances PTH stimulation of adenylyl cyclase but not phopholipase C. J. Biol. Chem. 270: 8458-8465.
58. 2-adrenergic receptor to Gi and Gs. J. Biol. Chem. 266: 4816-4821.
59. WONG, S. K. F. & E. M. Ross. 1995. Chimeric muscarinic cholinergic:β-adrenergic receptors that are functionally promiscuous among G proteins. J. Biol. Chem. 269: 18968-18976.
60. ABOOD, M. E., M. A. NOEL, J. S. FARNSWORTH & Q. TAO. 1994. Molecular cloning and expression of δ S-opioid receptor from rat brain. J. Neurosci. Res. 37: 714-719.
61. WANG, W. W., M. SHAHRESTANIFAR, J. JIN & R. D. HOWELLS. 1995. Studies on μ and δ opioid receptor selectivity utilizing chimeric and site-mutagenized receptors. Proc. Natl. Acad. Sci. USA 92: 12436-12440.
62. SHEN, K.-F. & S. M. CRAIN. 1990. Cholera toxin-A subunit blocks opioid excitatory effects on sensory neuron action potentials indicating mediation by Gs-linked opioid receptors. Brain Res. 525: 225-231.
63. SHEN, K.-F. & S. M. CRAIN. 1992. Chronic selective activation of excitatory opioid receptor functions in sensory neurons results in opioid "dependence" without tolerance. Brain Res. 597: 74-83.
64. CANNELLA, M. S., B. ODERFELD-NOWAK, M. GRADKOWSKA, M. SKUP, L. GAROFALO, A. C. CUELLO & R. W. LEDEEN. 1990. Derivatives of ganglioside GM1 as neuronotrophic agents: Comparison of in vivo and in vitro effects. Brain Res. 513: 286-294.
65. HAKOMORI, S.-I. & Y. IGARASHI. 1995. Functional role of glycosphingolipids in cell recognition and signaling. J. Biochem. 118: 1091-1103.
66. HAKOMORI, S.-I. 1993. Structure and function of sphingoglycolipids in transmembrane signaling and cell-cell interactions. Biochem. Soc. Trans. 21: 1952-1955.
67. YATES, A. J. & A. RAMPERSAUD. 1998. Shingolipids as receptor modulators: An overview. This issue.
68. BREMER, E. G., J. SCHLESSINGER & S.-I. HAKOMORI. 1986. Ganglioside-mediated modulation of cell growth, specific effects of GM3 on tyrosine phosphorylation of the epidermal growth factor receptor. J. Biol. Chem. 261: 2434-2440.
69. YATES, A. J., H. E. SAQR & J. VAN BROCKLYN. 1995. Ganglioside modulation of the PDGF receptor-A model for ganglioside functions. J. Neuro-Oncol. 24: 65-73.
70. MUTOH, T., A. TOKUDA, T. MIYADAI, M. HAMAGUCHI & N. FUJIKI, 1995. Ganglioside GM1 binds to the Trk protein and regulates receptor function. Proc. Natl. Acad. Sci. USA 92: 5087-5091.
71. KIELCZYNSKI, W., L. C. HARRISON & P. J. LEEDMAN. 1991. Direct evidence that ganglioside is an integral component of the thyrotropin receptor. Proc. Natl. Acad. Sci. USA 88: 1991-1995.
72. REISINE, T. & G. I. BELL. 1993. Molecular biology of opioid receptors. Trend. Neurosci. 16: 506-510.